AHA Comments to CMS on the International Pricing Index Model for Medicare Part B Drugs

AHA comments on the Centers for Medicare & Medicaid Services’ advance notice of proposed rulemaking on the International Pricing Index model for Medicare Part B drugs.

 

Sign In to Download the AHA Comments to CMS on the
International Pricing Index Model for Medicare Part B Drugs

Related Resources

Advisory
Trump Administration Issues Order on Drug Pricing
Member
AHA Center for Health Innovation Market Scan
RFID Solutions Attract Attention for Medication Inventory Management
Public
Letter/Comment
AHA Urges Administration to Grant Exceptions for Tariffs for Medications and Medical Supplies
Public
Fact Sheets
Fact Sheet: 340B Drug Pricing Program Contract Pharmacy Arrangements
Public
Letter/Comment
AHA Comments on CMS Proposed Medicare Drug Pricing Model
Public
Advisory
CMS Finalizes Guidance on Implementation of the Medicare Drug Price Negotiation Program
Member